Illumina (BSP:I1LM34) Net Change in Cash : R$-4,905 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Illumina Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Illumina's Net Change in Cash for the three months ended in Dec. 2023 was R$593 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was R$-4,905 Mil.

Illumina Net Change in Cash Historical Data

The historical data trend for Illumina's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Net Change in Cash Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

3,685.84

-1,193.57

-3,268.53

4,086.17

-4,718.51

Illumina Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															5,303.10	-2,692.85	286.37	-3,091.63	592.88

Illumina Net Change in Cash Calculation

Illumina's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	2342.104	+	-1131.854	+	-5928.758	+	0
	=	-4,719

Illumina's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1097.555 + -416.483 + -132.295 + 44.098

= 593

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-4,905 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Illumina's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (BSP:I1LM34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (BSP:I1LM34) » Definitions » Net Change in Cash

Comparable Companies

WAT LH ICLR MTD DGX CRL RVTY EXAS MEDP NTRA TSE:2309 TMO DHR IQV IDXX XSWX:LONN A SHSE:603259 XPAR:BIM XPAR:ERF

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany ILU:Germany ILU:Germany ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (BSP:I1LM34) Headlines

No Headlines